Sangamo BioSciences





Ebit Veränderung Datum
Alaunos Therapeutics USD -1.19M 148K 2025-09
Alnylam Pharmaceuticals USD -29.96M 34.85M 2025-09
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Amgen USD 3.96B 464M 2025-12
Bayer EUR -399M 363M 2025-09
BioCryst Pharmaceuticals USD -4.51M 12.2M 2024-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD -7.89M 536K 2025-09
CSL USD 2.75B 1.35B 2024-12
Gilead Sciences USD 3.51B 810M 2025-09
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 411.56M 15.51M 2025-09
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
J&J USD 5.11B 2.3B 2025-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Merck USD 6.24B 1.32B 2025-12
Novartis USD -9.19B 13.87B 2025-06
Omeros USD -48.15M 7.25M 2023-09
Pfizer USD 4.65B 71M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Tectonic Therapeutic USD -22.33M 4.03M 2025-06
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


Sangamo BioSciences - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.